Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Presenter: Freek W.A. Verheugt

October 30, 2016

REGISTER for free or LOG IN to view this content

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No – A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Structural Heart

Presentation

TCT 2016

Left Atrial Appendage

Up Next

Presentation TCT 2016

Optimal Device Selection for Carotid Stenting

Presenter: Rahul Sakhuja

October 30, 2016

More slides +

Presentation TCT 2016

Epidemiology and Treatment of Primary and Secondary Mitral Regurgitation: Global Perspectives

Presenter: Ralph Stephan von Bardeleben

October 30, 2016

Presentation TCT 2016

Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the Benefits Substantial?

Presenter: JoAnn Lindenfeld

October 30, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.